Search

  • Home
  • News
    • GenomeWeb Daily News
    • BioArray News
    • BioInform
    • In Sequence
    • PCR Insider
    • PGx Reporter
    • ProteoMonitor
    • RNAi News
  • Magazine
  • Blog
    • The Daily Scan
    • Informatics Iron
    • The Sample
  • Careers
    • Job Listings

Log in or Register
Tuesday, February 9, 2010
  • Arrays
  • Bioregionnews
  • Biotechtransferweek
  • Cbanews
  • DxPGx
  • Informatics
  • PCR/Sample Prep
  • Proteomics
  • RNAi
  • Sequencing
Home » News » ProteoMonitor

New Products

July 09, 2009
  • Type size: - +
  • Email
  • Printer-friendly version
  • RSS Feed

Applied Biosystems, NCBI

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.

Related Stories

  • Thermo Fisher 'Ruthlessly' Focused on Winning in Mass-Spec Space, CEO Tells Investors
    January 15, 2010 / ProteoMonitor
  • Thumbs Up All Around for Danaher Purchase of Life Tech, MDS' Mass Spec Business
    September 10, 2009 / ProteoMonitor
  • Life Tech’s Mass-Spec Revenue Falls 12 Percent in Q2; Total Receipts Rise 2 Percent
    July 30, 2009 / ProteoMonitor
  • Now a Stand-alone Firm, AB Sciex to Invest Further into R&D, Explore Acquisition Opportunities
    February 5, 2010 / ProteoMonitor
  • PerkinElmer Drops Legal Actions Against MDS, Life Tech; FTC Gives Nod to Analytical Technologies Sale
    January 29, 2010 / ProteoMonitor

In this issue of ProteoMonitor

  • NCI-Led Study Demonstrates Reproducibility of SID-MRM-MS for Protein Biomarker Verification
  • $6.8M Investment Pushes Pronota Closer To Development of Diagnostics Pipeline
  • Better than Gold? GWC Receives $100K ARRA Grant to Develop New Substrate for Protein Arrays
  • Mass Spec Firms Among Best Performers in GWDN Index
  • Young Investigator Profile

    Yuriy Kirichok
    Understanding mitochondrial mechanisms

    The Kirichok lab is combining powerful biophysical methods with genetics and molecular biology for the comprehensive study of the mitochondrial ion channels and mechanisms of their regulation. They are using the data from this work to uncover the fundamental physiological mechanisms that control mitochondrial functions. Through this process, Kirichok and his colleagues plan to identify mechanisms that can contribute to disease and will suggest effective therapeutic interventions based on manipulating mitochondrial ion channels.

  • Blog

    Ah, Grant Review

    A blogger is taking opinions concerning the NIH grant review process.

    February 09, 2010

    Outsourcing Sequencing

    Jeanne Loring wonders whether sequencing project will be outsourced to China.

    February 09, 2010

    A Drug Company and the Poor

    The New York Times profiles GlaxoSmithKline's Andrew Witty.

    February 09, 2010

    Keeping the Balance

    A blogger makes a list of family friendly companies.

    February 09, 2010
  • Papers of Note

    Multiple Copies of Ribosomal RNA Genes Aid Yeast Genome Integrity

    Mu et al., Nature Genetics

    Japanese researchers identified mechanisms through which ribosomal RNA gene sequences help protect the genome following DNA damage by comparing four Saccharomyces cerevisiae strains with 20, 40, 80, or 110 copies of genes coding for rRNA. They found that strains with fewer copies of rDNA genes were more sensitive to DNA damage by chemicals or ultraviolet light, apparently due to a role for these rDNA copies in recombination repair and sister chromatid cohesion.



    Team Maps Methylome During Cellular Differentiation

    Laurent, Wong, et al, Genome Research

    Using bisulfite sequencing with the Illumina Genome Analyzer, researchers from Singapore and the US mapped and compared DNA methylation patterns in human cells during three progressive stages of differentiation: embryonic stem cells, skin-like cells derived from embryonic stem cells, and primary neonatal skin cells. In the process, the team identified shared and cell type-specific methylation patterns, providing insights into how gene regulation shifts during development.

  • People on the Move

    NanoString Technologies has tapped William Young to serve as executive chairman of its board of directors. Young currently is chairman of the board at Biogen Idec, a director and chairman emeritus for BayBio, and a director at Theravance. He formerly was CEO and chairman at Monogram Biosciences, and he was COO at Genentech.


    RainDance Technologies has appointed Sirshendu Roopom Banerjee to be company president and CEO. Banerjee most recently led the Life Science Tools and Diagnostics sector at investment bank Leerink Swann, and he advised healthcare companies at McKinsey and Goldman Sachs. He also formerly worked at the Dana Farber Cancer Institute, the Whitehead Institute/MIT Human Genome Project, and at the Massachusetts General Hospital Cancer Center.


    Sequenom has appointed Wolfgang Holzgreve to its clinical advisory board. Holzgreve currently is director and chairman of the board of directors at the University Hospital Freiburg, Germany, and he formerly was chairman of the department and chief of service at the Department of Obstetrics and Gynecology, University of Basel.

  • Upcoming Events

    Conferences, Meetings & Deadlines

    Lorne Genome 2010
    Feb. 14-16 / Lorne, Victoria, Australia
    Lorne Genome Inc.

    AAAS Annual Meeting
    Feb. 18-22 / San Diego, CA
    AAAS

    22nd Annual Conference on Marketing Pharmaceuticals: Integrated Marketing, Emerging Media Trends, and New Regulations
    Feb. 22-24 / New York.
    The Drug Information Association

    2010 Personalized Medicine Partnerships Conference
    Feb. 22-24 / Philadelphia, PA
    Arrowhead Publishers and Conferences

    Programmatic Access to Biological Databases (Perl)
    Feb. 22–26 / Hinxton, UK
    EMBL-EBI

    Abstract & Registration Deadlines
    more
  • Science

    A team of researchers from has mapped and compared DNA methylation changes across the genome in human cells at three progressive stages of differentiation. The team was also able to gain insights into how methylation affects expression at different sites in the genome.
  • Business

    Qiagen subsidiary DxS will develop a companion diagnostic for a brain cancer treatment that Pfizer currently has in Phase 2 clinical trials. The real-time PCR assay will be used to identify patients whose tumors express the epidermal growth factor receptor variant III.
  • Funding

    The White House will seek a $1 billion, or a 3.2 percent, increase in funding for the National Institutes of Health, even though the overall budget for the fiscal year plans a freeze on non-military discretionary spending as part of an effort to reign in the federal deficit.
  • Genome Technology Magazine

    Check out this month's humor page.
    humor

TechGuides Listings

  • Genetic Variation
  • Tech Guide Archives

Poll

Powered by Drupal, an open source content management system
Copyright © 2010 Genomeweb LLC. All rights reserved. About | FAQ | Subscriptions | Contact us